跳至主要内容
临床试验/CTRI/2019/01/017302
CTRI/2019/01/017302招募中4 期

A comparative study of efficacy, safety and onset of action of vilazodone with escitalopram in patients of major depressive disorder at tertiary care hospital.

Dr Ankushe rohini0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients of either sex with age between 18 to
  • 2)Newly diagnosed MDD patients meeting DSM- 5
  • criteria for depression.
  • 3)Patient who give written informed consent.

排除标准

  • 1)Pregnant or nursing women.
  • 2)Patients with high risk of suicidal tendency
  • or previous suicide attempt within 6 months.
  • 3)Patients with bipolar disorder, drug abuse or
  • dependency, post traumatic stress disorder,
  • obsessive â?? compulsive disorder.
  • 4)Patients with previous depression resistant to
  • antidepressants and those who had taken treatment
  • with electroconvulsive therapy in previous 3
  • months or formal psychotherapy within 1 month.
  • 5)Patients on other antidepressants.
  • 6)Patients with neurological disorders (dementia,
  • seizures, stroke), obesity with functional
  • impairment, serious or unstable organic disorder
  • (neoplasia, cardiovascular, pulmonary,uncontrolled
  • type 1 or 2 diabetes).
  • 7)Any other medical disorder which is confounding
  • our inclusion diagnosis.
  • 8)Patients with drug intake for psychosis or anxiety.
  • 9)Any history of allergy to the drugs.

研究者

发起方
Dr Ankushe rohini

相似试验